•  
  •  
 

Document Type

Original Article

Abstract

Background: Among females, breast cancer has the highest incidence and is the leading cause of cancer-related death globally. Aim of the study: In contrast to invasive lobular carcinoma, the objective of this research is to examine how invasive duct carcinoma is managed. Patient and methods: This examined 200 women who were registered in the Al-Azhar University Hospitals database between January 2020 and December 2022 and were diagnosed with non-metastatic invasive breast cancer. The current investigation included cases with IDC or ILC histology based on the WHO classification's criteria. Results: The patient met the criteria for M0 illness by undergoing primary curative breast surgery, of which 170 (85%) were classified as IDC and 17 (8.5percent) as ILC. The remaining patients were ruled out of further research due to their diagnosis of different histological subtypes, 13 of which had mixed ILC and IDC. cases with ILC were offered mastectomy more often than those with IDC (79.4 vs. 67.7%). ILC cases had lower levels of HER2 positivity (9 vs. 18%) but higher levels of ER-positive illness (83 vs. 70%) and PgR-positive disease (75 vs. 60%) when compared to IDC individuals. Conclusion: ILC has unique biologic and prognostic characteristics that may call for various treatment modalities.

Keywords

Breast cancer; Egyptian women; clinical outcome; Invasive duct carcinoma

Subject Area

General Surgery

Download

Share

COinS